GE HealthCare to Release Third Quarter Earnings October 29
The medical technology company is scheduled to report its latest financial performance on Tuesday.
Updated on Oct. 28, 2026 in Healthcare
Live Poll
Do you generally trust that large corporations will meet their financial performance goals this quarter?
GE HealthCare will release its third-quarter financial results and host an earnings call on October 29, 2026. This announcement follows the company's performance in the second quarter, which concluded on June 30, 2026.
Why it matters
Investors and industry analysts look to these quarterly reports to gauge the company's financial health, operational progress, and its ability to manage inflationary pressures. The upcoming session provides insight into whether the firm can sustain its previous growth trends despite recent challenges in specific segments.
In the second quarter, GE HealthCare reported organic revenue growth of 3.5% and an 11.1% increase in organic orders. The company also recorded a backlog of $23.9 billion while the Patient Care Solutions segment saw a $26 million EBIT loss.
The players
GE HealthCare
This global medical technology company provides healthcare systems and services, including imaging, ultrasound, and patient care solutions.
The details
During the second fiscal quarter, the company achieved diluted earnings per share of $1.24, bolstered by tariff refunds and favorable tax rates. The Patient Care Solutions division faced headwinds, reporting $675 million in revenue, a 13.3% decrease compared to the same period the previous year.
Timeline
June 30, 2026 marked the conclusion of the second fiscal quarter.
October 28, 2026 is the date of publication.
October 29, 2026 is the date for the third quarter earnings release and call.
Market Landscape
This earnings report tracks the company's progress against its 2026 projections, including the anticipated $250 million in inflation costs. It reflects a broader corporate focus on navigating cost fluctuations to maintain projected organic revenue growth of 3% to 4%.
Shareholders and market observers should monitor the earnings call for updates on the company's financial trajectory and future growth plans. The results may offer insights into pricing strategies and product availability that could ultimately affect healthcare providers and customers.
The takeaway
Investors should review the upcoming release to see if the company's financial results justify its long-term growth forecasts for 2026. Monitoring these disclosures helps stakeholders understand the risks and opportunities within the medical technology market.
Further reading
For more on industry performance, see United States Healthcare.
Live Poll
Do you generally trust that large corporations will meet their financial performance goals this quarter?
